| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | melatonin (Circadin®) |
| Formulation | 2 mg prolonged-release tablet |
| Reference number | 197 |
| Indication | Monotherapy for the short term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over |
| Company | Lundbeck Ltd |
| BNF chapter | Central nervous system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 04/06/2008 |